Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla™ EGFR mutation test but is detected by ctDNA next generation sequencing and responds to osimertinib.

MLA

O’Sullivan, Hazel, et al. “Inadequacy of PCR Genotyping in Advanced Non-Small Cell Lung Cancer: EGFR L747_A755delinsSS Exon 19 Deletion Is Not Detected by the Real-Time PCR Idylla™ EGFR Mutation Test but Is Detected by CtDNA next Generation Sequencing and Responds to Osimertinib.” European Journal of Cancer (Oxford, England : 1990), vol. 166, May 2022, pp. 38–40. EBSCOhost, https://doi.org/10.1016/j.ejca.2022.02.007.

APA

O’Sullivan, H., d’Arienzo, P. D., Yousaf, N., Cui, W., & Popat, S. (2022). Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla™ EGFR mutation test but is detected by ctDNA next generation sequencing and responds to osimertinib. European Journal of Cancer (Oxford, England : 1990), 166, 38–40. https://doi.org/10.1016/j.ejca.2022.02.007

Chicago

O’Sullivan, Hazel, Paolo D d’Arienzo, Nadia Yousaf, Wanyuan Cui, and Sanjay Popat. 2022. “Inadequacy of PCR Genotyping in Advanced Non-Small Cell Lung Cancer: EGFR L747_A755delinsSS Exon 19 Deletion Is Not Detected by the Real-Time PCR Idylla™ EGFR Mutation Test but Is Detected by CtDNA next Generation Sequencing and Responds to Osimertinib.” European Journal of Cancer (Oxford, England : 1990) 166 (May): 38–40. doi:10.1016/j.ejca.2022.02.007.